Skip to main content

Bio-Matrix Signs Letter of Intent with Vibragene

NEW YORK (GenomeWeb News) – Bio-Matrix Scientific Group has signed a letter of intent with the genetic analysis and anti-aging specialty company Vibragene, under which it will negotiate an agreement to supply genetic testing for certain disease biomarkers.
 
Bio-Matrix said that Vibragene expects to send it 100,000 specimens during the next 12 months. The firm also said that the addition of the DNA testing capabilities complements its current business lines of processing and storing stem cells for future medical use.
 
The agreement between the two companies will depend upon a number of conditions, including establishing an acceptable price.

The Scan

Call to Look Again

More than a dozen researchers penned a letter in Science saying a previous investigation into the origin of SARS-CoV-2 did not give theories equal consideration.

Not Always Trusted

In a new poll, slightly more than half of US adults have a great deal or quite a lot of trust in the Centers for Disease Control and Prevention, the Hill reports.

Identified Decades Later

A genetic genealogy approach has identified "Christy Crystal Creek," the New York Times reports.

Science Papers Report on Splicing Enhancer, Point of Care Test for Sexual Transmitted Disease

In Science this week: a novel RNA structural element that acts as a splicing enhancer, and more.